Population
Human breast cancer cell line Hs578T
Design
Preclinical
Authors
Loading...
Suggests IGFBP-2 as apoptosis target in breast cancer; hypothesis-generating and requires in vivo validation before clinical consideration.
IGFBP-2 promotes apoptosis and alters gene expression in human breast cancer cells independent of IGF.
Frommer et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: